William K. Oh

ScholarGPS® ID: 94551389901898

Affiliation

Icahn School of Medicine at Mount Sinai, New York, United States

Affiliation History

Field

Medicine

Discipline

Hematology

Top Specialties

Metrics Summary

Publication Count

437

Predicted Citations

19,509

Predicted h-index

Ranking

Publications and Citation History

Publications based on Top Specialties

Types of Publication

Publications
Books
Patents
NIH/NSF

Add Delete
Prostate Cancer Foundation Screening Guidelines for Black Men in the United States (journal article) Garraway, Isla P. \| Carlsson, Sigrid V. \| Nyame, Yaw A. \| Vassy, Jason L. \| Chilov, Marina \| Fleming, Mark \| Frencher, Stanley K. \| George, Daniel J. \| Kibel, Adam S. \| King, Sherita A. \| ... \| Oh, William K. NEJM Evidence, volume 3, issue 5 (2024). 10.1056/EVIDoa2300289 Cited by (2) \| Cite \| Source
Final study analysis of PRINT: Prostate cancer intensive, non–cross-reactive therapy for CRPC. (journal article) Liaw, Bobby Chi-Hung \| Joshi, Himanshu \| Sheng, Tianxiang \| Tsao, Che-Kai \| Galsky, Matt D. \| Bakst, Richard Lorne \| Stewart, Robert \| Stock, Richard \| Oh, William K. Journal of Clinical Oncology, volume 42, issue 4_suppl, pages 147-147 (2024). 10.1200/JCO.2024.42.4_suppl.147 Cite \| Source
Prostate Cancer Foundation (PCF) screening guidelines for prostate cancer in Black men in the United States. (journal article) Garraway, Isla \| Carlsson, Sigrid V. \| Nyame, Yaw A. \| Vassey, Jason \| Chilov, Marina \| Fleming, Mark T. \| Frencher, Stanley K \| George, Daniel J. \| Kibel, Adam S. \| King, Sherita A \| ... \| Oh, William K. Journal of Clinical Oncology, volume 42, issue 4_suppl, pages 264-264 (2024). 10.1200/JCO.2024.42.4_suppl.264 Cited by (2) \| Cite \| Source
Risk Factors for Early Treatment Discontinuation Due to Toxicity Among Patients With Metastatic Castration-resistant Prostate Cancer Receiving Androgen Receptor–targeted Therapy (journal article) Chakrani, Zakaria \| Mellgard, George \| Saffran, Nathaniel \| McCroskery, Stephen \| Taylor, Nicole \| Patel, Mann \| Liaw, Bobby \| Galsky, Matthew \| Oh, William K. \| Tsao, Che-Kai \| Patel, Vaibhav G. American Journal of Clinical Oncology, volume 47, issue 6, pages 271-278 (2024). 10.1097/COC.0000000000001087 Cite \| Source
Effect of concurrent beta-blocker use in patients receiving immune checkpoint inhibitors for advanced solid tumors (journal article) Mellgard, George \| Patel, Vaibhav G. \| Zhong, Xiaobo \| Joshi, Himanshu \| Qin, Qian \| Wang, Bo \| Parikh, Anish \| Jun, Tomi \| Alerasool, Parissa \| Garcia, Philip \| ... \| Tsao, Che-Kai Journal of Cancer Research and Clinical Oncology, volume 149, issue 7, pages 2833-2841 (2023). 10.1007/s00432-022-04159-y Cited by (4) \| Cite \| Source
Real world utilization and outcomes of immunotherapy regimens in metastatic castration resistant prostate cancer (mCRPC). (journal article) Ganta, Teja \| Anker, Jonathan Forrest \| Miller, Eric James \| Tsao, Kai \| Oh, William K. Journal of Clinical Oncology, volume 41, issue 16_suppl, pages e17038-e17038 (2023). 10.1200/JCO.2023.41.16_suppl.e17038 Cite \| Source
Analysis of real-world data to investigate evolving treatment sequencing patterns in advanced non-small cell lung cancers and their impact on survival (journal article) Liu, Zongzhi \| Lee, Kyeryoung \| Cohn, David \| Zhang, Mingwei \| Ai, Lei \| Li, Minghao \| Zhang, Xingming \| Jun, Tomi \| Higashi, Mitchell K. \| Pan, Qi \| ... \| Li, Shuyu D. Journal of Thoracic Disease, volume 15, issue 5, pages 2438-2449 (2023). 10.21037/jtd-22-1481 Cite \| Source
Biomarker Development Trial of Satraplatin in Patients with Metastatic Castration-Resistant Prostate Cancer (journal article) Liaw, Bobby C \| Tsao, Che-Kai \| Seng, Sonia \| Jun, Tomi \| Gong, Yixuan \| Galsky, Matthew D \| Oh, William K The Oncologist, volume 28, issue 4, pages 366-e224 (2023). 10.1093/oncolo/oyac224 Cited by (1) \| Cite \| Source
Oncologist-driven development of an electronic health record (EHR) clinical data visualization tool for prostate cancer. (journal article) Ganta, Teja \| Anker, Jonathan Forrest \| Miller, Eric James \| Kannry, Joseph \| Bhardwaj, Aarti Sonia \| Tsao, Kai \| Oh, William K. Journal of Clinical Oncology, volume 41, issue 6_suppl, pages 267-267 (2023). 10.1200/JCO.2023.41.6_suppl.267 Cite \| Source
Risk factors for treatment (tx) toxicity and discontinuation among patients (pts) with metastatic castration-resistant prostate cancer (mCRPC) on androgen receptor targeted therapy (ART). (journal article) Chakrani, Zakaria \| Mellgard, George Slade \| Mccroskery, Stephen \| Saffran, Nathaniel \| Taylor, Nicole \| Liaw, Bobby Chi-Hung \| Oh, William K. \| Tsao, Kai \| Patel, Vaibhav G. Journal of Clinical Oncology, volume 41, issue 6_suppl, pages 135-135 (2023). 10.1200/JCO.2023.41.6_suppl.135 Cite \| Source
Clinical characteristics and outcomes of trial-ineligible patients (pts) with metastatic castration-resistant prostate cancer (mCRPC) receiving androgen receptor targeted (ART) therapy. (journal article) Mellgard, George Slade \| Mccroskery, Stephen \| Chakrani, Zakaria \| Saffran, Nathaniel \| Taylor, Nicole \| Liaw, Bobby Chi-Hung \| Galsky, Matt D. \| Oh, William K. \| Tsao, Kai \| Patel, Vaibhav G. Journal of Clinical Oncology, volume 41, issue 6_suppl, pages 118-118 (2023). 10.1200/JCO.2023.41.6_suppl.118 Cite \| Source
Survival outcomes and toxicity in older adults with metastatic castration-resistant prostate cancer (mCRPC) treated with androgen receptor targeted (ART) therapies. (journal article) Mellgard, George Slade \| Chakrani, Zakaria \| Mccroskery, Stephen \| Saffran, Nathaniel \| Taylor, Nicole \| Liaw, Bobby Chi-Hung \| Galsky, Matt D. \| Oh, William K. \| Tsao, Kai \| Patel, Vaibhav G. Journal of Clinical Oncology, volume 41, issue 6_suppl, pages 117-117 (2023). 10.1200/JCO.2023.41.6_suppl.117 Cite \| Source
Detecting Ground Glass Opacity Features in Patients With Lung Cancer: Automated Extraction and Longitudinal Analysis via Deep Learning–Based Natural Language Processing (journal article) Lee, Kyeryoung \| Liu, Zongzhi \| Chandran, Urmila \| Kalsekar, Iftekhar \| Laxmanan, Balaji \| Higashi, Mitchell K \| Jun, Tomi \| Ma, Meng \| Li, Minghao \| Mai, Yun \| ... \| Wang, Xiaoyan JMIR AI, volume 2 (2023). 10.2196/44537 Cited by (1) \| Cite \| Source
Pediatric Age at Hematopoietic Stem Cell Transplant: Associations with Non-Malignant Genetic Disease and Race (journal article) Higashi, Mitchell K. \| Kruszka, Paul \| Francis, Marra S. \| Parsons, Kelly K. \| Oh, William K. \| Onel, Kenan Blood, volume 140, issue Supplement 1, pages 7973-7974 (2022). 10.1182/blood-2022-170315 Cite \| Source
Treatment Profile of CAR-T Cell Therapy Induced Cytokine Release Syndrome and Neurotoxicity: Insights from Real-World Evidence (journal article) Lee, Kyeryoung \| Paek, Hunki \| Ai, Lei \| Liu, Zongzhi \| Jin, Lan \| Li, Minghao \| Jun, Tomi \| Higashi, Mitchell K. \| Onel, Kenan \| Oh, William K. \| ... \| Wang, Xiaoyan Blood, volume 140, issue Supplement 1, pages 12750-12752 (2022). 10.1182/blood-2022-166716 Cited by (2) \| Cite \| Source
Prevalence of Pathogenic Germline Mutations in Solid Tumor Predisposition Genes Detected By Tumor-Normal Whole Exome Sequencing Analysis Among Adults with Hematologic Malignancies (journal article) Al-Kateb, Hussam \| Jun, Tomi \| Hayes, Jim \| Rossi, Michael \| Hantash, Feras \| Oh, William K. \| Onel, Kenan Blood, volume 140, issue Supplement 1, pages 7852-7853 (2022). 10.1182/blood-2022-159618 Cite \| Source
Clinical actionability and utilization of next-generation sequencing for prostate cancer in a changing treatment landscape (journal article) Griffin, Jacqueline \| Tsao, Che-Kai \| Patel, Vaibhav \| Liaw, Bobby C. \| Guin, Sunny \| Joshi, Himanshu \| Rossi, Michael \| Hantash, Feras \| Zhou, Xiang \| Tewari, Ash \| ... \| Jun, Tomi Frontiers in Urology, volume 2 (2022). 10.3389/fruro.2022.997396 Cited by (2) \| Cite \| Source
Seasonal variations of hospitalizations for chronic rhinosinusitis by different endotypes (journal article) Jin, Lan \| Govindaraj, Satish \| Liu, Zongzhi \| Ai, Lei \| Higashi, Mitchell \| Jun, Tomi \| Lee, Kyeryoung \| Raja, Kalpana \| Zhang, Xingmin \| Li, Minghao \| ... \| Wang, Xiaoyan ISEE Conference Abstracts, volume 2022, issue 1 (2022). 10.1289/isee.2022.P-1062 Cite \| Source
1274P Performance status (PS) and end-of-life (EOL) care in patients (pts) with metastatic prostate cancer (mPC) treated with androgen receptor targeted (ART) therapy (journal article) Mellgard, G. \| Chakrani, Z. \| McCroskery, S. \| Saffran, N. \| Taylor, N. \| Liaw, B. \| Galsky, M.D. \| Oh, W. \| Tsao, C-K. \| Patel, V. Annals of Oncology, volume 33 (2022). 10.1016/j.annonc.2022.07.1407 Cite \| Source
Management of de novo metastatic hormone-sensitive prostate cancer: A comprehensive report of a single-center experience (journal article) Guin, Sunny \| Liaw, Bobby K. \| Jun, Tomi \| Ayers, Kristin \| Patel, Bonny \| O’Connell, Timmy \| Deitz, Matthew \| Klein, Michael \| Mullaney, Tommy \| Prentice, Tony \| ... \| Oh, William K. PLOS ONE, volume 17, issue 8, pages e0264800- (2022). 10.1371/journal.pone.0264800 Cited by (1) \| Cite \| Source

Title	Investigators	Year	Cost	Agency
P-4: Modulating Transcription Factor Targets Via Chemical Genomics	OH, William K.	2011	$298,353	NATIONAL CANCER INSTITUTE
P-4: Modulating Transcription Factor Targets Via Chemical Genomics	OH, William K.	2010	$314,056	NATIONAL CANCER INSTITUTE
A phase II study of IPI-504 in metastatic hormone refractory prostate cancer	OH, William K.	2009	$263,979	NATIONAL CANCER INSTITUTE
Modulating Transcription Factor Targets Via Chemical Genomics	OH, William K.	2009	$245,931	NATIONAL CANCER INSTITUTE
A phase II study of IPI-504 in metastatic hormone refractory prostate cancer	OH, William K.	2008	$268,452	NATIONAL CANCER INSTITUTE
Modulating Transcription Factor Targets Via Chemical Genomics	OH, William K.	2008	$245,933	NATIONAL CANCER INSTITUTE
Modulating Transcription Factor Targets Via Chemical Genomics	OH, William K.	2007	$245,732	NATIONAL CANCER INSTITUTE